Table of Contents Author Guidelines Submit a Manuscript
PPAR Research
Volume 2014 (2014), Article ID 537865, 11 pages
Research Article

PPARG in Human Adipogenesis: Differential Contribution of Canonical Transcripts and Dominant Negative Isoforms

1Institute of Genetics and Biophysics “Adriano Buzzati-Traverso”, National Research Council, 80131 Naples, Italy
2Department of Translational Medical Sciences, University of Naples “Federico II”, 80131 Naples, Italy
3Institute of Experimental Endocrinology and Oncology, National Research Council, 80131 Naples, Italy

Received 25 November 2013; Revised 3 February 2014; Accepted 5 February 2014; Published 23 March 2014

Academic Editor: Guangrui Yang

Copyright © 2014 M. Aprile et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


The nuclear receptor PPARγ is a key regulator of adipogenesis, and alterations of its function are associated with different pathological processes related to metabolic syndrome. We recently identified two PPARG transcripts encoding dominant negative PPARγ isoforms. The existence of different PPARG variants suggests that alternative splicing is crucial to modulate PPARγ function, underlying some underestimated aspects of its regulation. Here we investigate PPARG expression in different tissues and cells affected in metabolic syndrome and, in particular, during adipocyte differentiation of human mesenchymal stem cells. We defined the transcript-specific expression pattern of PPARG variants encoding both canonical and dominant negative isoforms and identified a novel PPARG transcript, γ1ORF4. Our analysis indicated that, during adipogenesis, the transcription of alternative PPARG variants is regulated in a time-specific manner through differential usage of distinct promoters. In addition, our analysis describes—for the first time—the differential contribution of three ORF4 variants to this process, suggesting a still unexplored role for these dominant negative isoforms during adipogenesis. Therefore, our results highlight crucial aspects of PPARG regulation, suggesting the need of further investigation to rule out the differential impact of all PPARG transcripts in both physiologic and pathologic conditions, such as metabolism-related disorders.